Banner Image

Resources

California’s Copay Coupon Bill Stirs Up Panic—Here’s What Pharmaceutical Brand Teams Need To Know.

Oct 16, 2017 | Trends, Insights & Analysis
How to navigate California's AB-265, a bill designed to curb the use of copay coupons for branded prescription drugs when a generic version is available.
Read more ▸▸

Prescription Drug News of Note - October 2017

Oct 15, 2017 | Trends, Insights & Analysis
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Truveris Ranks on Crain's 2017 Fast 50 List of Fastest-Growing New York Companies

Oct 11, 2017 | News
Truveris was named to Crain's Fast 50 list of fastest growing companies in New York, with a notable growth rate of 501% powered by our innovative technology.
Read more ▸▸

Is Your Patient Abandonment Rate Really What You Think it is?

Oct 2, 2017 | Trends, Insights & Analysis
Determining your brand’s true patient abandonment rate starts with understanding the data from key steps along the patient journey.
Read more ▸▸

How Artificial Intelligence in Healthcare is Helping Physicians Better Prescribe Treatments

Sep 21, 2017 | Trends, Insights & Analysis
The growing use of AI in healthcare is leading to more effective individualized treatments and greater patient access.
Read more ▸▸

Alysha Fluno Joins Truveris as Chief Pharmacy Officer

Sep 15, 2017 | News
Truveris announces the addition of Chief Pharmacy Officer Alysha Fluno, who will bring expertise from a diverse background in the pharmacy industry.
Read more ▸▸

Prescription Drug News of Note - September 2017

Sep 11, 2017 | Trends, Insights & Analysis
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications

Sep 6, 2017 | Press Releases
McKesson Ventures led the funding round with existing investors to advance the company’s data and insights capabilities, which help manage rising prescription drug costs.
Read more ▸▸

Is Your Copay Program Ready For 2018?

Aug 24, 2017 | Trends, Insights & Analysis
It’s after Labor Day and you have spent the summer carefully brand planning and strategically evaluating the tactics you need to put in place for 2017.
Read more ▸▸

What is a Pharmacy Benefit Manager (PBM) and how Does a PBM Impact the Pharmacy Benefits Ecosystem?

Aug 15, 2017 | Trends, Insights & Analysis
Pharmacy Benefits Managers play an important and often complicated role in the prescription benefits industry. Learn more on the Truveris blog.
Read more ▸▸

Is Your Copay Program Costing You More Than It’s Earning? Keep These Top 5 Metrics In Mind

Aug 11, 2017 | Trends, Insights & Analysis
While the strategy and goals of every copay program vary, we’ve found that the top 5 essential metrics to track ROI stay the same.
Read more ▸▸

State of New Jersey Cutting Prescription Drug Spend by 18% with Truveris TruBid® & Bill Review Technology

Aug 7, 2017 | Press Releases
The outcome of a contract between Truveris and the State of New Jersey to assist with reducing the State’s prescription drug spend will result in a savings of approximately 18%.
Read more ▸▸

Prescription Drug News of Note – August 2017

Aug 1, 2017 | Trends, Insights & Analysis
A rundown of the latest FDA approvals and regulations from August 2017, with an expert take on what you need to know in the prescription drug industry.
Read more ▸▸

Rick Dade Joins the Truveris Team as Director of National Labor Sales

Jul 30, 2017 | News
Director of National Labor Sales Rick Dade joins the Truveris team.
Read more ▸▸

State Adopts Sweeney Plan To Save $1.5 Billion In Prescription Drug Costs

Jul 5, 2017 | News
New Jersey Senator Steve Sweeney's plan results in over $1 billion in savings for the state
Read more ▸▸

NJEA: Union-led Effort Nets $1.6 Billion in Prescription Savings

Jul 5, 2017 | News
Truveris reverse-auction technology helps the State of New Jersey save on prescription benefits cost.
Read more ▸▸

Wall Street Journal: Health-Care VCs Take Aim at High Drug Prices

Jun 8, 2017 | News
CEO Faisal Mushtaq shares his insights on how Truveris is bringing transparency to prescription drug pricing.
Read more ▸▸

Truveris Announces Appointment of Laurent Schockmel as Senior Vice President of Business Development

May 22, 2017 | News
Truveris announces appointment of Laurent Schockmel as senior vice president of business development.
Read more ▸▸

Jeff Ignaszak Joins Truveris as Chief Marketing Officer

May 17, 2017 | News
Jeff Ignaszak joins Truveris as chief marketing officer.
Read more ▸▸

Prescription Drug Prices Continue to Climb, Soaring 8.77% in Latest Truveris NDI Report

May 10, 2017 | Press Releases
Prescription drug prices soared 8.77% in 2016, representing the fourth consecutive year of inflation above 8%.
Read more ▸▸

Truveris Announces Appointment of Peter Day as Director of National Employer Sales

May 10, 2017 | News
Truveris announces appointment of Peter Day as Director of National Employer Sales.
Read more ▸▸

Truveris Selected by New Jersey to Implement Reverse Auction and Price Transparency Platform for Pharmaceutical Benefits

Apr 28, 2017 | News
Truveris selected by New Jersey to implement reverse auction and price transparency platform for pharmaceutical benefits.
Read more ▸▸

Truveris Strengthens Leadership Team with Appointment of Tim Herlehy as Chief Revenue Officer

Jan 9, 2017 | News
Truveris strengthens leadership team with appointment of Tim Herlehy as chief revenue officer
Read more ▸▸

The Keys To A Successful Partnership

Dec 12, 2016 | Trends, Insights & Analysis
Use these five tips to create a productive relationship with your partner to ensure your copay program’s success.
Read more ▸▸

The Single Question You Are Missing From Your RFP

Nov 16, 2016 | Trends, Insights & Analysis
Selecting the right strategic partner can be a challenge and a Request for Proposal (RFP) is an important part of the selection process.
Read more ▸▸

Truveris Ranked Number 131 Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500™

Nov 16, 2016 | News
Truveris Ranked Number 131 Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500.
Read more ▸▸

Truveris to Participate in “62nd Annual Employee Benefits Conference”

Nov 3, 2016 | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at an event, titled 62nd Annual Employee Benefits Conference.
Read more ▸▸

Truveris to Participate in “The Shift to Outcome-Based Care: Redefining how we Consume and Pay for Health Care”

Oct 31, 2016 | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at The Shift to Outcome-Based Care: Redefining how we Consume and Pay for Health Care.
Read more ▸▸

Top 5 Copay Program Fallacies

Oct 25, 2016 | Trends, Insights & Analysis
There are many common misconceptions associated with designing or managing your copay program. Don’t be fooled by them, as they are likely hindering your performance.
Read more ▸▸

Are You Considering The Right Segmentation Options For Your Copay Program?

Oct 13, 2016 | Trends, Insights & Analysis
When it comes to designing your copay program, chances are you haven’t considered all of the options.
Read more ▸▸

Truveris to Participate in “23rd Annual Health & Benefits Expo”

Oct 3, 2016 | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at an event, titled 23rd Annual Health & Benefits Expo hosted by Teamster Center Services.
Read more ▸▸

Truveris to Participate in “High Value Health: Making the Dream a Reality” Conference

Sep 23, 2016 | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at High Value Health: Making the Dream a Reality hosted by NBCH.
Read more ▸▸

Truveris Strengthens Leadership Team with Appointment of Faisal Mushtaq as Chief Executive Officer

Sep 22, 2016 | Press Releases
Truveris, a leading provider of solutions across the prescription drug ecosystem, announced the appointment of Faisal Mushtaq as the chief executive officer.
Read more ▸▸

Truveris to Participate in “Strata + Hadoop World” Conference

Sep 20, 2016 | Events
Vice President of Data Science Joanne Chen will participate at an event, titled “Strata + Hadoop World” hosted by O’Reilly and Cloudera.
Read more ▸▸

Truveris to Participate in “Coupon and Co-Pay Offer Design Optimization” Conference

Sep 12, 2016 | Events
Vice President of Life Sciences Elizabeth Pattyn will participate at an event, titled “Coupon and Co-Pay Offer Design Optimization” hosted by CBI.
Read more ▸▸

Treato: Healthcare Insights Company Examines Patients’ Attitudes Towards Costs Related to Xtandi, Ibrance and Xarelto

Jul 19, 2016 | News
Treato announced that patients feel entitled to a drug discount program when prescribed a costly new drug
Read more ▸▸

EBN: Truveris' Bertrand Janin Ranked Amongst EBN’s 50 Benefit Technology Innovators

Jun 17, 2016 | News
As CTO of Truveris, Bertrand Janin oversees a team of engineers, product designers and analysts who create and maintain the healthcare startup’s products.
Read more ▸▸

How Can 340B Pricing Help Healthcare Organizations Save On Medications?

May 25, 2016 | Trends, Insights & Analysis
As prescription drug prices continue to increase, consumers are finding it increasingly difficult to pay for their medications.
Read more ▸▸

10 Questions Employers Should Be Asking About the Cadillac Tax

Apr 20, 2016 | Trends, Insights & Analysis
The Cadillac Tax is an excise tax levied on employers that provide high-cost health benefit plans to their employees.
Read more ▸▸

What Is A Single Source Generic And How Does It Impact Drug Pricing?

Apr 7, 2016 | Trends, Insights & Analysis
Before signing up for any new insurance plan, you should familiarize yourself with an often overlooked segment of insurance – your pharmacy benefits plan.
Read more ▸▸

Exploring the Price of Medication

Mar 29, 2016 | Trends, Insights & Analysis
Drug prices have increased dramatically over the past decade. But only 17 percent of consumers shop around for drugs to see if they can get better deal.
Read more ▸▸

Consumers Increasingly Walk Away from Prescription Drugs When Prices Reach $50, Creating Trend Toward Medication Abandonment, According to Truveris Data

Mar 22, 2016 | Press Releases
Consumers increasingly walk away from prescription drugs that treat medical conditions when prices reach the $50 threshold.
Read more ▸▸

How Do Genes Affect Drug Response?

Mar 16, 2016 | Trends, Insights & Analysis
Have you ever wondered why some medications work for certain people but not others? Why might you experience side effects from a drug while your friend doesn’t?
Read more ▸▸

Employee Benefit News: How Express Scripts is Looking to Hold Down Drug Prices

Mar 14, 2016 | News
According to the OneRx National Drug Index, in 2015 the cost of brand drugs was up 14.77%; specialty prices jumped 9.21% and generics cost 2.93% more.
Read more ▸▸

WLOS News 13: The Real Cost of Your Prescription and Why Shopping Can Save You Money

Mar 2, 2016 | News
Over the last year, prescription costs have shot up more than any other category of medical care.
Read more ▸▸

3 Novel Ways Medication May Impact Your Health

Mar 1, 2016 | Trends, Insights & Analysis
Drugs affect everyone differently. So when you’re prescribed a medication, what factors dictate how it will impact your health?
Read more ▸▸

Time: 13 Smart Ways to Save on Prescription Drugs

Feb 29, 2016 | News
Prescription-drug spending grew 12.2% in 2014—five times as fast as the year before—according to the Centers for Medicare & Medicaid Services.
Read more ▸▸

Pharmaceutical Executive: How Did Things Get This Bad? Look in the Mirror, US Pharma

Feb 29, 2016 | News
There has to be a lot of head-shaking going on in the C-suites of many U.S. pharmaceutical companies.
Read more ▸▸

Palm Beach Daily News: Island Pharmacists React to Rising Prescription Drug Costs

Feb 19, 2016 | News
The former Turing Pharmaceutical executive rose to international notoriety after his company raised the price of Daraprim by 5,000 percent.
Read more ▸▸

GOBankingRates: Over 40% of Americans Expect to Pay More for Healthcare in 2016

Feb 16, 2016 | News
Many of the most common health-related costs that Americans face increased over the course of 2015 or are set to increase in 2016.
Read more ▸▸

Pharmaceutical Processing: Brand Name Statins Still Favored by Consumers

Jan 27, 2016 | News
Treato, a leading consumer healthcare website, revealed their first annual list of top statins.
Read more ▸▸

Drug Store News: Patients still Prefer Brand-Name Statins

Jan 27, 2016 | News
The ranking shows that, despite widespread availability of generics for popular brand-name statins, patient satisfaction is higher with brand-name drugs.
Read more ▸▸

The Wall Street Journal: A New Prescription for Lower Drug Prices

Jan 25, 2016 | News
For three years in a row, according to a recent survey by health-care data company Truveris, prescription-drug prices in the U.S. have risen by double digits.
Read more ▸▸

Today’s Credit Unions: Prescription Drug Price Continue to Rise in Double Digits

Jan 24, 2016 | News
According to the latest figures from the OneRx National Drug Index, prescription drug prices rose 10.43% in 2015.
Read more ▸▸

The Palm Beach Post: West Palm Beach Doctor, Daughter Exposes Drug Price Hikes up to 1,700%

Jan 22, 2016 | News
Prices rose an average of 401 percent on 19 prescription drugs for skin conditions.
Read more ▸▸

Healthzette: Why You Can’t Afford Your Medication

Jan 15, 2016 | News
Prescription drug costs have been rising faster than general inflation.
Read more ▸▸

Talk Business & Politics: 11.3 Million Individuals Sign up for Obamacare Through Health Insurance Marketplaces

Jan 15, 2016 | News
More than 11.3 million people are signed up for coverage through the Health Insurance Marketplaces in all 50 states and the District of Columbia.
Read more ▸▸

The Daily Journal: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 13, 2016 | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

CBS News: ​Drugmakers Ring in 2016 with Hefty Price Hikes

Jan 12, 2016 | News
Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month.
Read more ▸▸

FirstWord Pharma: Price of Prescription Drugs Rose over 10 Percent in US Last Year

Jan 12, 2016 | News
US prescription drug prices lifted 10.43 percent in 2015, with the cost of branded medicines jumping 14.77 percent.
Read more ▸▸

FiercePharma: What Public Outcry? New Year Brings Dozens of Double-Digit Drug Price Hikes

Jan 12, 2016 | News
The market researchers at Truveris have another update: Branded prescription drug prices went up 14.5% last year overall.
Read more ▸▸

The State Journal-Register: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

The Washington Post: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

The Columbus Dispatch: Drug Prices up More than 10 Percent in 2015

Jan 11, 2016 | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

Business Insurance: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

Specialty Pharma Journal: New Report Finds Prescription Drug Prices Rose 10.43 Percent in 2015

Jan 11, 2016 | News
Prescription drug prices rose 10.43 percent in 2015 – squeezing American household budgets and adding fuel to the debate around healthcare costs.
Read more ▸▸

Chicago Tribune: Prescription Drug Prices Jumped More than 10 Percent in 2015,

Jan 11, 2016 | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

St. Louis Post-Dispatch: Prescription Drug Prices Jumped More Than 10 Percent in 2015,

Jan 11, 2016 | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

InsuranceNewsNet: Prescription Drug Prices Climbed 10.43% in 2015

Jan 11, 2016 | News
Prescription drug prices rose 10.43 percent in 2015 – squeezing American household budgets and adding fuel to the debate around healthcare costs.
Read more ▸▸

Reuters: Pfizer Hikes U.S. Prices for Over 100 Drugs on January 1

Jan 8, 2016 | News
Pfizer Inc on Jan. 1 raised U.S. prices for more than 100 of its drugs, some by as much as 20 percent, according to statistics compiled by Wolters Kluwer.
Read more ▸▸

The Traverse City Record Eagle: No COLA Increase Should Infuriate and Energize Seniors

Oct 27, 2015 | News
About 65 million seniors were informed on Oct. 15 that there would be no Social Security annual cost of living adjustment (COLA) for 2016.
Read more ▸▸

American Journal of Managed Care: 2015 Sees a More Gradual Slope to Prescription Drug Prices

Oct 27, 2015 | News
A new analysis by the healthcare technology firm Truveris, reports that prescription drug prices rose 9.1% through September 30, 2015, for all medicines.
Read more ▸▸

Fortune: Why the Drug Price Scandal won’t be Enough to Keep Down Prices

Oct 26, 2015 | News
Daraprim captured national attention in September when Turing Pharmaceuticals boosted the price of the lifesaving toxoplasmosis treatment by over 5,000%.
Read more ▸▸

Pharmalot: Prescription Drug Price Hikes are Slowing this Year

Oct 26, 2015 | News
The price tags for prescription drugs are a red-hot issue that is increasingly causing concern among consumers, physicians and insurers.
Read more ▸▸

Drug Channels: Three Ways The C-Suite Can Prepare for the Cadillac Tax

Oct 23, 2015 | News
Leon discusses “the Cadillac tax,” a federal tax employers will pay on higher priced employee health benefit plans.
Read more ▸▸

Chief Executive: Pharma CEOs Grapple With Huge R&D Costs

Oct 22, 2015 | News
Turing Pharmaceuticals CEO Martin Shkreli hiked the price of Daraprim—a drug used to treat patients with AIDS, cancer, and malaria—by about 5,445%.
Read more ▸▸

TheStreet: Prescription Drug Costs Rising Again Even Among Generic Medications

Oct 21, 2015 | News
Prescription drug prices are expected to spike again, especially among some generic medications, following last year’s swift increase.
Read more ▸▸

MainStreet: Prescription Drug Costs Rise Again

Oct 21, 2015 | News
Prescription drug prices are expected to spike again, especially among some generic medications, following last year’s swift increase.
Read more ▸▸

USA Today: Stagnant Social Security Check Could Pose Hardship for Some

Oct 16, 2015 | News
Millions of Social Security recipients who depend on the program for most of their income will have to cut back on necessities such as food and medical care.
Read more ▸▸

Xconomy: Q&A with Biotech Venture Vet Nina Kjellson

Sep 30, 2015 | News
Nina Kjellson has been a biotech investor for 15 years, having spent the last 13 at InterWest Partners in Menlo Park, CA, and now moving to Canaan Partners.
Read more ▸▸

Fortune: Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach

Sep 29, 2015 | News
Drug prices have taken center stage since Turing Pharmaceuticals raised the price of its off-patent parasite-fighting drug Daraprim by over 5,000%.
Read more ▸▸

Mic: Hedge Fund Manager's Turing Pharmaceuticals Raises 62-Year-Old Drug From $13.50 to $750

Sep 21, 2015 | News
Daraprim used to cost just $13.50 per dose. Now it's $750 for each and every tablet.
Read more ▸▸

Truveris to Participate in “Analytics Experience 2016” Conference

Sep 5, 2015 | Events
Vice President of Data Science Joanne Chen will participate at an event, titled “Analytics Experience 2016” hosted by SAS Institute.
Read more ▸▸

CNBC: More Americans Cut Spending to Pay for Prescription Drugs

Aug 18, 2015 | News
One-third of Americans who regularly take prescription medication are seeing price hikes this year.
Read more ▸▸

New App Helps Consumers Find More Ways to Save on Prescription Drugs

Aug 5, 2015 | Press Releases
OneRx enables consumers to review drug pricing and benefits data, offering the most robust prescription drug savings tool in the marketplace.
Read more ▸▸

The Washington Post: How new drugs helping millions of Americans live longer are also making them go broke

Jun 30, 2015 | News
If you pay for good health insurance, shouldn’t you be able to afford the medicine you need?
Read more ▸▸

Employee Benefit News: Plan Design Changes Required to Curb Rising Rx Drug Prices

May 1, 2015 | News
Prescription drug prices jumped another 3.8% in the first quarter of 2015, adding to the fears of employers concerned about increasing health care costs.
Read more ▸▸

Employee Benefit News: Generic Drugs Beat Explosive Price Trends in Health Plans

May 1, 2015 | News
Generic pharmaceuticals have maintained their “laggard” status compared to branded and specialty drugs with respect to rising prices.
Read more ▸▸

Valued Pharmacy Services: 2015 Prescription Drug Prices Jump Another 3.8% in Q1, According to Truveris National Drug Index

Apr 29, 2015 | News
Truveris continues to spotlight prescription drug cost increases with 2015 data from the Truveris National Drug Index (NDI).
Read more ▸▸

2015 Prescription Drug Prices Jump Another 3.8% in Q1, According to Truveris National Drug Index

Apr 28, 2015 | Press Releases
Truveris continues to spotlight prescription drug cost increases with 2015 data from the Truveris National Drug Index (NDI).
Read more ▸▸

Life Health Pro: Stop-Loss, The Market Plumbers

Mar 20, 2015 | News
Some of the bigger small employers are thinking of stop-loss programs as a health benefits life raft.
Read more ▸▸

American Pharmacy News: Truveris Launches Pharmacy Stop Loss Insurance Platform

Mar 17, 2015 | News
Truveris introduces a new product that will enable benefits brokers and advisers to help companies take advantage of stop loss insurance.
Read more ▸▸

Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefits Costs

Mar 17, 2015 | Press Releases
Truveris has introduced a new product to enable benefits brokers and advisors help companies more easily take advantage of stop loss insurance.
Read more ▸▸

Bloomberg News: The Drug Pipeline Flows Again

Feb 26, 2015 | News
One new drug, Bristol-Myers Squibb’s Opdivo, boosted one-year survival rates in trials to 73 percent from 42 percent for standard chemotherapy.
Read more ▸▸

Financial Times: The Race to Cure Rising Drug Costs

Feb 10, 2015 | News
Since contracting hepatitis C 25 years ago, Lucinda Porter’s biggest fear has been that she would infect someone else with the deadly virus. “Whenever I cut myself and saw the smeared blood, I would panic,” she says.
Read more ▸▸

Aging Care: Did You Notice the Big Jump in Drug Costs from 2013 to 2014?

Feb 3, 2015 | News
If you’re an average citizen who required prescription medication in 2014, you paid about 10.9 percent more than you did in 2013.
Read more ▸▸

Business Journal: Branded Drug Prices Spike 15 Percent

Jan 30, 2015 | News
Branded drug prices spiked nearly 15% last year, according to the latest data from the Truveris National Drug Index.
Read more ▸▸

FiercePharma: Branded Drug Prices Leapt Almost 15% Last Year, Led by Pain Pills, COPD and Heart Meds

Jan 29, 2015 | News
U.S. consumers saw prescription med prices vault 10.9% in 2014, according to the Truveris National Drug Index.
Read more ▸▸

Healthy Skeptic: Truveris Drug Price Index

Jan 28, 2015 | News
The Truveris National Drug Index gathers and publishes data on medication pricing.
Read more ▸▸

Clinical Informatics News: Drug Prices Rose Across Classes in 2014

Jan 28, 2015 | News
On Monday, the Truveris National Drug Index released its first full year figures. In 2014, generic and specialty drugs combined rising 10.9%.
Read more ▸▸